Holding(s) in Company

AI SummaryClose X

On October 6, 2025, Immupharma PLC announced that Lanstead Capital Investors LP crossed a threshold related to major holdings. The notification, dated October 2, 2025, reveals that Lanstead Capital Investors LP now holds 4.99% of the voting rights attached to shares, a decrease from the previously notified 8.99%. This change reflects a holding of 25,108,044 ordinary shares out of a total of 502,723,932 voting rights attached to shares. The notification indicates an acquisition or disposal of voting rights as the reason for the change.

Disclaimer*

Companies

Immupharma (IMM)
UK 100

Latest directors dealings